Home » Authors » Aaron Lorenzo

Aaron Lorenzo

Articles

ARTICLES

Potential Partner Backpedals From Emisphere Insulin Deal

March 6, 2003

By Aaron Lorenzo

Financially Uncertain Essential Seeks To Divest Some Assets

March 6, 2003

By Aaron Lorenzo

Financially Uncertain Essential Seeks To Divest Some Assets

March 6, 2003

By Aaron Lorenzo

Potential Partner Backpedals From Emisphere Insulin Deal

March 6, 2003

By Aaron Lorenzo

Viragen Continues Restructuring To Sustain Remaining Resources

March 5, 2003

By Aaron Lorenzo

YM BioSciences Receives FDA Nod For Phase III Cancer Trial

March 5, 2003

By Aaron Lorenzo

YM BioSciences Receives FDA Nod For Phase III Cancer Trial

March 5, 2003

By Aaron Lorenzo

Viragen Continues Restructuring To Sustain Remaining Resources

March 5, 2003

By Aaron Lorenzo

AnorMED's Fosrenol Receives Approvable Letter From FDA

March 4, 2003

By Aaron Lorenzo

The regulatory approval horizon appears closer than ever for the kidney disease drug Fosrenol. (BioWorld Today)

AnorMED's Fosrenol Receives Approvable Letter From FDA

March 4, 2003

By Aaron Lorenzo

The regulatory approval horizon appears closer than ever for the kidney disease drug Fosrenol. (BioWorld Today)

View All Articles by Aaron Lorenzo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...